We next sought to directly address the impact of endogenous RNF12/Rlim XLID mutation on RNF12 substrate processing and stem cell differentiation using a CRISPR/Cas9 knockin strategy. The gene discussed is RLIM; the disease is cask-related x-linked intellectual disability.